| abstract |
The present invention relates to 4-methylsulfonyl-2-butenenitrile, or a pharmaceutically acceptable salt thereof, one isomer or a plurality of isomers. The invention also relates to a pharmaceutical composition comprising a pharmaceutically acceptable carrier and 4-methylsulfonyl-2-butenenitrile, or a pharmaceutically acceptable salt, one isomer or multiple isomers thereof. The present invention further relates to a method for treating inflammation, inflammation-related disorders or pain, in which 4-methylsulfonyl-2-butenenitrile, or a pharmaceutically acceptable salt or solvate thereof is used in a subject in need thereof. The present invention relates to a method for administering a product. |